Index of reports
> Cases with Hepatic Function Abnormal (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rifadin (Rifampin) where reactions include hepatic function abnormal. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Rifadin side effects in female
Reported by a physician from Japan on 2012-04-02
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remicade
Indication: Psoriatic Arthropathy
Start date: 2011-08-08
Remicade
Start date: 2011-06-14
Remicade
Indication: Psoriasis
Start date: 2011-08-08
Remicade
Start date: 2010-12-01
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2011-10-27
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-04-19
Remicade
Start date: 2011-06-14
Remicade
Start date: 2010-12-28
Remicade
Start date: 2011-02-22
Remicade
Start date: 2010-12-28
Remicade
Start date: 2010-12-01
Remicade
Start date: 2011-02-22
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-04-19
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Other drugs received by patient: Loxoprofen Sodium; Zithromax; Voltaren; Urso 250; Pyridoxal Phosphate; Rebamipide
Possible Rifadin side effects in female
Reported by a physician from Japan on 2012-03-16
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Indication: Psoriatic Arthropathy
Start date: 2011-08-08
Remicade
Start date: 2010-12-28
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Remicade
Indication: Psoriasis
Start date: 2011-08-08
Remicade
Start date: 2011-06-14
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-02-22
Remicade
Start date: 2011-04-19
Remicade
Start date: 2010-12-28
Remicade
Start date: 2010-12-01
Remicade
Start date: 2011-02-22
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2011-10-27
Remicade
Start date: 2010-11-16
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Start date: 2011-06-14
Remicade
Start date: 2010-12-01
Remicade
Start date: 2011-04-19
Other drugs received by patient: Zithromax; Loxoprofen Sodium; Pyridoxal Phosphate; Rebamipide; Urso 250; Voltaren
Possible Rifadin side effects in female
Reported by a physician from Japan on 2012-03-14
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remicade
Indication: Psoriasis
Start date: 2010-11-16
Remicade
Start date: 2011-08-08
Remicade
Start date: 2011-02-22
Remicade
Start date: 2010-12-01
Remicade
Start date: 2011-04-19
Remicade
Start date: 2010-12-01
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-10-27
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Indication: Psoriatic Arthropathy
Start date: 2011-08-08
Remicade
Start date: 2011-06-14
Remicade
Start date: 2011-02-22
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Remicade
Start date: 2011-06-14
Remicade
Start date: 2011-04-19
Remicade
Start date: 2010-12-28
Remicade
Start date: 2010-11-16
Remicade
Start date: 2010-12-28
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Other drugs received by patient: Zithromax; Voltaren
Possible Rifadin side effects in female
Reported by a physician from Japan on 2012-02-29
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remicade
Start date: 2011-04-19
Remicade
Start date: 2010-12-28
Remicade
Start date: 2011-06-14
Remicade
Indication: Psoriasis
Start date: 2010-11-16
Remicade
Start date: 2010-12-01
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Indication: Psoriatic Arthropathy
Start date: 2011-08-08
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Remicade
Start date: 2011-02-22
Remicade
Start date: 2010-12-01
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-10-27
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Start date: 2011-06-14
Remicade
Start date: 2011-04-19
Remicade
Start date: 2011-02-22
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-08-08
Remicade
Start date: 2010-12-28
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
Other drugs received by patient: Zithromax; Voltaren
Possible Rifadin side effects in female
Reported by a physician from Japan on 2012-02-07
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-08-08
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Indication: Psoriatic Arthropathy
Start date: 2010-12-28
Remicade
Start date: 2011-04-19
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Remicade
Indication: Psoriasis
Start date: 2010-11-16
Remicade
Start date: 2011-06-14
Remicade
Start date: 2010-12-28
Remicade
Start date: 2011-02-22
Remicade
Start date: 2011-04-19
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Start date: 2011-08-08
Remicade
Start date: 2010-12-01
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Start date: 2010-12-01
Remicade
Start date: 2011-06-14
Remicade
Start date: 2011-02-22
Other drugs received by patient: Voltaren; Zithromax
Possible Rifadin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-12
Patient: female
Reactions: Hepatic Function Abnormal, Renal Impairment
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ethambutol Hydrochloride
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2010-03-03
End date: 2010-03-06
Rifadin
Indication: Extrapulmonary Tuberculosis
End date: 2010-03-01
Ethambutol Hydrochloride
Administration route: Oral
Indication: Extrapulmonary Tuberculosis
Start date: 2010-03-06
End date: 2010-03-09
Levofloxacin
Indication: Disseminated Tuberculosis
Start date: 2010-03-06
End date: 2010-03-09
Levofloxacin
Start date: 2010-03-03
End date: 2010-03-06
Streptomycin
Indication: Extrapulmonary Tuberculosis
Start date: 2010-02-26
End date: 2010-03-06
Streptomycin
Start date: 2010-03-06
End date: 2010-03-09
Streptomycin
Indication: Pulmonary Tuberculosis
Start date: 2010-03-06
End date: 2010-03-09
Levofloxacin
Start date: 2010-03-03
End date: 2010-03-06
Rifadin
Indication: Pulmonary Tuberculosis
End date: 2010-03-01
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2010-03-03
End date: 2010-03-06
Levofloxacin
Indication: Pulmonary Tuberculosis
Start date: 2010-03-06
End date: 2010-03-09
Streptomycin
Start date: 2010-02-26
End date: 2010-03-06
Levofloxacin
Indication: Extrapulmonary Tuberculosis
Start date: 2010-03-06
End date: 2010-03-09
Levofloxacin
Start date: 2010-03-03
End date: 2010-03-06
Ethambutol Hydrochloride
Administration route: Oral
Start date: 2010-03-06
End date: 2010-03-09
Other drugs received by patient: Ciprofloxacin Hydrochloride; Cefazolin Sodium; Humulin R; Verapamil HCL; Bactrim; Lasix; Alendronate Sodium; Hicaliq; Rheumatrex; Sodium Bicarbonate; Digoxin; Lansoprazole; Aminoleban EN; Vitaject; Sodium Bicarbonate; Fentanyl; Rheumatrex; Folic Acid; Mineral; Ciprofloxacin Hydrochloride; Ensure; Lactulose; Prednisolone; Dopamine HCL; Aminoleban
Possible Rifadin side effects in female
Reported by a physician from Japan on 2011-12-08
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Hepatic Function Abnormal, Peritoneal Tuberculosis, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remicade
Indication: Psoriatic Arthropathy
Start date: 2010-12-28
Remicade
Start date: 2011-06-14
Remicade
Start date: 2010-12-28
Rifadin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Ethambutol Hydrochloride
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Pyrazinamide
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Remicade
Indication: Psoriasis
Start date: 2010-11-16
Remicade
Start date: 2011-08-08
Remicade
Start date: 2010-12-01
Remicade
Start date: 2010-11-16
Remicade
Start date: 2011-06-14
Remicade
Start date: 2011-04-19
Remicade
Start date: 2011-02-22
Remicade
Start date: 2011-02-22
Remicade
Start date: 2010-12-01
Neoiscotin
Administration route: Oral
Indication: Tuberculosis
Start date: 2011-09-09
End date: 2011-10-26
Neoiscotin
Administration route: Oral
Start date: 2010-10-25
End date: 2011-05-17
Remicade
Start date: 2011-08-08
Remicade
Start date: 2011-04-19
Other drugs received by patient: Voltaren; Zithromax
Possible Rifadin side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-20
Patient: male
Reactions: Hepatic Function Abnormal, Liver Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Isoniazid
Indication: Pulmonary Tuberculosis
Rifadin
Indication: Pulmonary Tuberculosis
Levofloxacin
Indication: Pulmonary Tuberculosis
Ciprofloxacin
Indication: Pulmonary Tuberculosis
Ethambutol Hydrochloride
Indication: Pulmonary Tuberculosis
Possible Rifadin side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-11
Patient: male
Reactions: Death, Hepatic Function Abnormal, Liver Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Isoniazid
Indication: Pulmonary Tuberculosis
Ethambutol Hydrochloride
Indication: Pulmonary Tuberculosis
Levofloxacin
Indication: Pulmonary Tuberculosis
Rifadin
Indication: Pulmonary Tuberculosis
Ciprofloxacin
Indication: Pulmonary Tuberculosis
|